Trilostane, sold under the brand names Desopan, Modrastane, and Modrenal among others, is a steroidogenesis inhibitor which is used in the treatment of Cushing’s syndrome It was withdrawn from human use in the United States market in April 1994.[4][5] The drug was previously available in the United Kingdom for use in humans under the brand name Modrenal for the treatment of Cushing’s disease and for breast cancer
| Product Name: | Trilostane |
| Synonyms: | Trilostane;(2-alpha,4-alpha,5-alpha,17-beta)-4,5-epoxy-17-hydroxy-3-oxoandrostane-2-car;17-beta)-ph;4-alpha,5-epoxy-17-beta-hydroxy-3-oxo-5-alpha-androstane-2-alpha-carbonitril;4-alpha,5-epoxy-3,17-dihydroxy-5-alpha-androst-2-ene-2-carbonitrile;4-alpha-5-epoxy-17-beta-hydroxy-3-oxo-5-alpha-androstane-2-alpha-carbonitril;androstane-2-carbonitrile,4,5-epoxy-17-hydroxy-3-oxo-,(2-alpha,4-alpha,5-al;modrenal |
| CAS: | 13647-35-3 |
| MF: | C20H27NO3 |
| MW: | 329.43 |
| EINECS: | 237-133-0 |